000 | 01450 a2200421 4500 | ||
---|---|---|---|
005 | 20250513002334.0 | ||
264 | 0 | _c19801125 | |
008 | 198011s 0 0 eng d | ||
022 | _a0002-9149 | ||
024 | 7 |
_a10.1016/0002-9149(80)90015-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGreenspan, A M | |
245 | 0 | 0 |
_aLarge dose procainamide therapy for ventricular tachyarrhythmia. _h[electronic resource] |
260 |
_bThe American journal of cardiology _cSep 1980 |
||
300 |
_a453-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnorexia _xchemically induced |
650 | 0 | 4 | _aAntibodies, Antinuclear |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xdrug therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJoint Diseases _xchemically induced |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 |
_aProcainamide _xadverse effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aHorowitz, L N | |
700 | 1 | _aSpielman, S R | |
700 | 1 | _aJosephson, M E | |
773 | 0 |
_tThe American journal of cardiology _gvol. 46 _gno. 3 _gp. 453-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(80)90015-6 _zAvailable from publisher's website |
999 |
_c6967831 _d6967831 |